Science
Mechanism of Action
Mimics the N-terminal end of the SNAP-25 protein to compete for binding sites in the SNARE complex, disrupting the release of neurotransmitters like acetylcholine from nerve endings and subsequently reducing muscle contractions that cause expression lines
Research
Clinical Evidence
Medium confidence10%
Key findings
- 01 28-day study with 10% solution (0.005% active peptide) showed 34.98% reduction in wrinkle depth versus 27.05% with Argireline
- 02 14-week multi-peptide clinical trial demonstrated significant improvement in eye lines (P=0.003) and eye wrinkles (P=0.007) by week 10
Transparency
Dusting Analysis
Given that effective concentrations require 3-10% of commercial solution containing 0.005% active peptide, products with minimal peptide content would be ineffective for neuromuscular modulation
The Formula
Formulation
Stability
Susceptible to hydrolysis at extreme pH values and prone to oxidation/deamidation due to methionine and aspartic acid residues; requires proper stabilization in slightly acidic environments
Synergies
- Other peptides
- Hyaluronic acid
- Antioxidants
Conflicts
- Strong oxidizers
- Proteolytic enzymes
- Extreme pH formulations
Safety
Safety Profile
Safety profile inferred from related Acetyl Hexapeptide-8 which has been CIR-reviewed and deemed safe up to 0.005% pure peptide concentration
Your Skin
Skin Compatibility
Our Assessment
Verdict
A well-researched peptide with demonstrated efficacy for expression lines, though requiring proper formulation and adequate concentrations to deliver meaningful results.
Related
Similar Ingredients
Finding similar ingredients…